Holen Sie sich die Stockscreener-App
231.12
3.44%
7.69
Vorhandelsmarkt:
231.15
0.03
+0.01%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HUM?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$223.43
Offen:
$224.05
24-Stunden-Volumen:
1.62M
Relative Volume:
0.92
Marktkapitalisierung:
$27.89B
Einnahmen:
$117.76B
Nettoeinkommen (Verlust:
$1.21B
KGV:
23.23
EPS:
9.95
Netto-Cashflow:
$2.39B
1W Leistung:
+4.16%
1M Leistung:
-3.55%
6M Leistung:
-18.88%
1J Leistung:
-39.96%
1-Tages-Spanne:
$223.91
$231.93
1-Wochen-Bereich:
$206.87
$231.93
52-Wochen-Spanne:
$206.87
$406.09
Humana Inc Stock (HUM) Company Profile
Firmenname
Humana Inc
Sektor
Branche
Telefon
(502) 580-1000
Adresse
500 W MAIN ST, LOUISVILLE, KY
Vergleichen Sie HUM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
231.12 | 26.78B | 117.76B | 1.21B | 2.39B | 9.95 |
|
UNH
Unitedhealth Group Inc
|
285.13 | 264.62B | 410.06B | 22.11B | 24.86B | 23.88 |
|
CI
Cigna Group
|
300.05 | 80.79B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
61.08 | 80.89B | 378.96B | 5.28B | 5.94B | 4.19 |
|
ELV
Elevance Health Inc
|
281.72 | 75.71B | 189.25B | 5.36B | 5.34B | 23.50 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-01 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-11-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-10-07 | Herabstufung | Jefferies | Buy → Hold |
| 2024-10-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-10-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-10-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-10-02 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-02 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-03-22 | Eingeleitet | Raymond James | Mkt Perform |
| 2024-03-13 | Herabstufung | Argus | Buy → Hold |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-12 | Hochstufung | Argus | Hold → Buy |
| 2023-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-07-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-06-23 | Herabstufung | Argus | Buy → Hold |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-10-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-09-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-04-13 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-04 | Bestätigt | Barclays | Overweight |
| 2021-11-04 | Bestätigt | Credit Suisse | Outperform |
| 2021-11-04 | Bestätigt | Morgan Stanley | Overweight |
| 2021-11-04 | Bestätigt | Oppenheimer | Outperform |
| 2021-11-04 | Bestätigt | RBC Capital Mkts | Outperform |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-09-09 | Fortgesetzt | Barclays | Overweight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Neutral |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-01-04 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-16 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-06-05 | Eingeleitet | Goldman | Buy |
| 2020-01-03 | Bestätigt | JP Morgan | Overweight |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | Eingeleitet | UBS | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-08 | Bestätigt | BofA/Merrill | Buy |
| 2018-09-13 | Eingeleitet | Barclays | Overweight |
| 2018-07-12 | Fortgesetzt | Morgan Stanley | Overweight |
| 2018-07-06 | Bestätigt | Piper Jaffray | Overweight |
| 2018-06-01 | Fortgesetzt | Citigroup | Buy |
| 2018-02-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | Bestätigt | Leerink Partners | Outperform |
| 2018-01-12 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Humana Inc Aktie (HUM) Neueste Nachrichten
What analysts say about Humana Inc. stockSpectacular growth rates - Autocar Professional
Humana commits to eliminating prior authorization for certain CT, MR imaging exams - Radiology Business
Humana Inc. (NYSE:HUM) Shares Purchased by AMG National Trust Bank - MarketBeat
Humana Asks Texas Court To Void 2025 Medicare Ratings - Law360
Humana files second lawsuit challenging Medicare Advantage star ratings - HealthExec
Humana Inc. Stock Analysis and ForecastExplosive earnings growth - jammulinksnews.com
Humana to Reduce About One-Third of Prior Authorization Requirements - HealthLeaders Media
Humana pledges to accelerate reductions in time, number of prior authorizations - Medical Economics
Humana Moves To Cut Prior Authorization Delays, Streamline Care Approvals - Benzinga
Humana to reduce prior authorizations for outpatient services - TechTarget
Humana refiles Medicare Advantage ratings lawsuit against CMS - Modern Healthcare
Humana to drop some outpatient prior authorization requirements - Modern Healthcare
Humana refiles Medicare Advantage star ratings suit - Healthcare Dive
Humana to reduce about one-third of prior authorization requirements - Reuters
Humana Refiles Challenge to Medicare Quality Rating Cut - Bloomberg Law News
Kennondale Capital Management LLC Cuts Stock Holdings in Humana Inc. (NYSE:HUM) - MarketBeat
Humana To Slash Red Tape Around Prior Authorization For Care Services By 2026: Retail Remains Optimistic - Stocktwits
Humana: CenterWell And Medicaid Key To Offset MA Star Ratings Worries (NYSE:HUM) - Seeking Alpha
Humana's Sharp Decline And Star Rating Troubles Lead Me To Stay Neutral For Now (NYSE:HUM) - Seeking Alpha
What drives Humana Inc. stock priceFree Stock Selection - jammulinksnews.com
Is Humana Inc. a good long term investmentExplosive capital appreciation - jammulinksnews.com
Humana to reduce prior authorization requirements - Reuters
Humana refiles Medicare Star Ratings lawsuit; to slash prior authorization requirements - Seeking Alpha
Humana to reduce prior authorization requirements By Reuters - Investing.com
Humana (HUM) Streamlines Prior Authorization to Boost Efficiency - GuruFocus
Humana to cut prior authorization requirements by one-third - Investing.com Australia
Humana's Strategic Shift in Prior Authorization: A Catalyst for Operational Efficiency and Investor Value - AInvest
Humana Accelerates Efforts to Eliminate Prior Authorization Requ - GuruFocus
Humana to reduce prior authorizations, streamline care approval process By Investing.com - Investing.com Canada
Humana Accelerates Efforts To Eliminate Prior Authorization Requirements To Ensure A Faster, More Seamless Process - TradingView
Where UnitedHealthcare, Humana rule the Medicare Advantage market - Modern Healthcare
Humana to eliminate one-third of prior authorizations by 2026 - StreetInsider
Humana Accelerates Efforts to Eliminate Prior Authorization Requirements to Ensure a Faster, More Seamless Process - Business Wire
Humana Refiles Lawsuit Against Federal Government Over Medicare Advantage Star Ratings Methodology - geneonline.com
Humana refiles Medicare Advantage ratings lawsuit against federal government - statnews.com
Humana renews challenge to downgrade of US Medicare 'star' ratings | Business Information & News | FE - Westlaw Today
Humana Inc. (NYSE:HUM) Shares Purchased by South Dakota Investment Council - MarketBeat
Humana Inc. (NYSE:HUM) Shares Bought by Victory Capital Management Inc. - MarketBeat
Humana renews challenge to downgrade of US Medicare ’star’ ratings By Reuters - Investing.com
Humana renews challenge to downgrade of US Medicare 'star' ratings - Reuters
Epic pulls Humana insurance coverage information into MyChart - Healthcare IT News
Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of Humana Inc. (NYSE:HUM) - MarketBeat
Humana stock unchanged as UBS reiterates Neutral rating after court ruling - Investing.com Canada
Humana stock rebounds after court dismisses Medicare Advantage rating lawsuit By Investing.com - Investing.com South Africa
Humana stock rebounds after court dismisses Medicare Advantage rating lawsuit - Investing.com
Taking a holistic approach to integrated care - Crain's Detroit Business
Humana Launches Share Buyback Program--Authorized to Repurchase Up to 1.5 Million Shares - MarketScreener
Bridgewater Advisors Inc. Makes New Investment in Humana Inc. (NYSE:HUM) - MarketBeat
Cwm LLC Buys 17,947 Shares of Humana Inc. (NYSE:HUM) - MarketBeat
Humana Inc. (NYSE:HUM) Shares Bought by Pzena Investment Management LLC - MarketBeat
Humana Lawsuit Dismissed Over Medicare Star Ratings, Stock Drops 7% - Industry Leaders Magazine
Finanzdaten der Humana Inc-Aktie (HUM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.68%
1.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):